Overview An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes Status: Completed Trial end date: 2011-09-01 Target enrollment: Participant gender: Summary This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes. Details Lead Sponsor: AllerganTreatments: Bimatoprost